136 related articles for article (PubMed ID: 1650667)
1. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
[TBL] [Abstract][Full Text] [Related]
2. Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study.
Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
Curr Eye Res; 1991; 10 Suppl():183-7. PubMed ID: 1907535
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.
Maudgal PC; Missotten L; De Clercq E; Descamps J; De Meuter E
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):261-8. PubMed ID: 7020469
[TBL] [Abstract][Full Text] [Related]
4. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
5. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.
Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
Br J Ophthalmol; 1991 Nov; 75(11):649-51. PubMed ID: 1751456
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
Maudgal PC; De Clercq E; Missotten L
Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
[TBL] [Abstract][Full Text] [Related]
7. Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.
van Bijsterveld OP; Meurs PJ; de Clercq E; Maudgal PC
Br J Ophthalmol; 1989 Aug; 73(8):604-7. PubMed ID: 2669938
[TBL] [Abstract][Full Text] [Related]
8. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
9. Herpetic keratitis. Proctor Lecture.
Kaufman HE
Invest Ophthalmol Vis Sci; 1978 Oct; 17(10):941-57. PubMed ID: 100465
[TBL] [Abstract][Full Text] [Related]
10. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
12. Oral antiviral drugs in experimental herpes simplex keratitis.
Kaufman HE; Varnell ED; Centifanto-Fitzgerald YM; De Clercq E; Kissling GE
Antimicrob Agents Chemother; 1983 Dec; 24(6):888-91. PubMed ID: 6318664
[TBL] [Abstract][Full Text] [Related]
13. Vidarabine therapy of complicated herpes simplex keratitis.
O'Day DM; Poirier RH; Jones DB; Elliott JH
Am J Ophthalmol; 1976 May; 81(5):642-9. PubMed ID: 1275044
[TBL] [Abstract][Full Text] [Related]
14. [Clinical resistance of herpetic keratitis to antiviral agents (author's transl)].
Colin J; Chastel C; Baikoff G; Renard G
J Fr Ophtalmol; 1981; 4(1):57-60. PubMed ID: 6260850
[TBL] [Abstract][Full Text] [Related]
15. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
Maudgal PC; De Clercq E; Huyghe P
Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
17. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
Maudgal PC; De Clercq E; Descamps J; Missotten L
Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
[No Abstract] [Full Text] [Related]
19. [BVDU therapy in herpes corneae].
Benad A; Richter E
Klin Monbl Augenheilkd; 1989 Jun; 194(6):424-6. PubMed ID: 2761189
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration.
Wilhelmus KR; Coster DJ; Donovan HC; Falcon MG; Jones BR
Arch Ophthalmol; 1981 Sep; 99(9):1578-82. PubMed ID: 6793030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
